Citius Pharmaceuticals Inc (CTXR)
0.5219
0.00 (0.00%)
USD |
NASDAQ |
Sep 27, 16:00
0.5218
0.00 (0.00%)
After-Hours: 20:00
Citius Pharmaceuticals Net Income (Annual): -32.54M for Sept. 30, 2023
Net Income (Annual) Chart
Historical Net Income (Annual) Data
| Date | Value |
|---|---|
| September 30, 2023 | -32.54M |
| September 30, 2022 | -33.64M |
| September 30, 2021 | -23.05M |
| September 30, 2020 | -17.55M |
| September 30, 2019 | -15.56M |
| September 30, 2018 | -12.54M |
| Date | Value |
|---|---|
| September 30, 2017 | -10.38M |
| September 30, 2016 | -8.296M |
| September 30, 2015 | -2.902M |
| September 30, 2013 | -0.0314M |
| September 30, 2012 | -0.022M |
| September 30, 2011 | -0.0263M |
Net Income Definition
Net Income is the total amount of profit earned by a company. This metric boils down to the overall profit that is left from the revenue that a company receives after taking out various operational line items like cost of goods sold, income tax expense, SG&A expense, etc. Eventually, all companies would want to have a consistent positive and growing net income, so that this can be used for various purposes like reinvesting into the company, paying off debt, and potentially paying out dividends to shareholders.
Net Income (Annual) Range, Past 5 Years
-33.64M
Minimum
2022
-15.56M
Maximum
2019
-24.47M
Average
-23.05M
Median
2021
Net Income (Annual) Benchmarks
| Agilent Technologies Inc | 1.24B |
| Seelos Therapeutics Inc | -37.88M |
| Cara Therapeutics Inc | -118.51M |
| Moleculin Biotech Inc | -29.77M |
| Citius Oncology Inc | -- |